Literature DB >> 2446799

Pharmacologic relevance of dihydropyridine binding sites in membranes from rat aorta: kinetic and equilibrium studies.

M Wibo1, L DeRoth, T Godfraind.   

Abstract

The kinetic features of the interaction of dihydropyridines with rat aortic smooth muscle were investigated in parallel mechanical and binding studies. The inhibitory action of (+)-PN200-110 and nisoldipine on contractions evoked by potassium chloride depolarization was characterized by a pronounced time dependency, in which the inhibition increased slowly after depolarization to attain a steady-state value, while with (-)-PN200-110 and (+)-Bay K8644 the inhibition was almost instantaneous. To explain these observations, specific binding sites for dihydropyridines were studied in membranes isolated from rat aorta, using [3H](+)-PN200-110 as a radioligand. We found that the time course of the development of inhibition of potassium chloride-evoked contractions by various concentrations of (+)-PN200-110 paralleled the time course of [3H](+)-PN200-110 binding to isolated membranes and that the level of inhibition was predictable from the level of occupation of these binding sites. These results indicate that depolarization increases the affinity of calcium channels for dihydropyridines in vascular smooth muscle and that the time course of the inhibitory effect on contraction is determined by the time course of association with the high-affinity state of the channel.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2446799     DOI: 10.1161/01.res.62.1.91

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  15 in total

1.  Dihydropyridine enantiomers block recombinant L-type Ca2+ channels by two different mechanisms.

Authors:  R Handrock; R Rao-Schymanski; N Klugbauer; F Hofmann; S Herzig
Journal:  J Physiol       Date:  1999-11-15       Impact factor: 5.182

2.  Regulation of the L-type calcium channel alpha-1 subunit by chronic depolarization in the neuron-like PC12 and aortic smooth muscle A7r5 cell lines.

Authors:  O Feron; T Godfraind
Journal:  Pflugers Arch       Date:  1995-07       Impact factor: 3.657

3.  Pharmacological properties of voltage-dependent calcium channels in functional microvessels isolated from rat brain.

Authors:  N Morel; T Godfraind
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

4.  Characterisation of marrubenol, a diterpene extracted from Marrubium vulgare, as an L-type calcium channel blocker.

Authors:  Sanae El-Bardai; Maurice Wibo; Marie-Christine Hamaide; Badiaa Lyoussi; Joelle Quetin-Leclercq; Nicole Morel
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

5.  Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.

Authors:  S Salomone; T Godfraind
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

6.  Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta.

Authors:  B F del Pozo; F Pérez-Vizcaíno; E Villamor; F Zaragozá; J Tamargo
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

Review 7.  Cardioselectivity of calcium antagonists.

Authors:  T Godfraind
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

8.  Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery.

Authors:  N Morel; T Godfraind
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

9.  Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine.

Authors:  N Morel; T Godfraind
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

10.  Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.

Authors:  O Feron; M Wibo; M O Christen; T Godfraind
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.